Dr. Di Hong was appointed Chief Executive Officer of Nona Biosciences on October 14, 2025, taking leadership of the Cambridge-based global biotechnology company specializing in antibody discovery and development. Based in Shanghai and reporting to Chairman Dr. Jingsong Wang, Hong is tasked with accelerating Nona's innovation in antibody discovery and development.
Dr. Hong brings over 20 years of leadership experience spanning science, operations, and strategy. He holds a Doctor of Business Administration from Université Nice Sophia Antipolis, as well as Master's and Bachelor's degrees in Chemistry from Zhejiang University. This dual scientific and business training positions him to navigate both the technical and strategic dimensions of biotech innovation and commercialization.
Career History
- CEO, Gaoyue Group (life science infrastructure platform of Hillhouse Capital), Built a national life science network and established a "Lab-to-Market" ecosystem
- Senior leadership roles at Hua Medicine, Bioduro-Sundia, Amgen, Eli Lilly, and Roche in China, Blending global and local expertise across biopharma, CRO, and investment sectors
What Dr. Di Hong could bring to CEO at Nona Biosciences: His track record of building innovative ecosystems and bridging global-local expertise across biopharma, CRO, and investment positions him to execute Nona's strategic growth agenda. His ecosystem-building experience at Gaoyue Group suggests capability to expand Nona's partnerships, integrate AI and external capital, and evolve the "Service Plus" business model into a platform-powered innovation network. His chemistry background combined with 20+ years managing science, operations, and strategy suggests depth to lead both technical platform advancement and commercial scaling in the competitive antibody-discovery space.
This is an automatically generated Light profile created by Executive Moves editorial systems from verified public announcements. Information is kept deliberately concise until the page is claimed and enriched.
Facts compiled by Executive Moves from publicly available news and press releases on 3 July 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you Dr. Di Hong?
This is a Light profile, auto-generated from public news coverage. Claim it to verify your bio, add a photo and links, and control how your career is represented on Executive Moves.
Claim this profile →
